These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 26821501)

  • 21. Signs and symptoms of ocular surface status in glaucoma patients switched from timolol 0.5% to brinzolamide 1%/timolol 0.5% fixed combination: a 6-month efficacy and tolerability, multicenter, open-label prospective study.
    Rossi GC; Tinelli C; Pasinetti GM; Fusetti M; Pallavicini C; Stringa M; Vacchi S; Stringa F; Bianchi PE
    Expert Opin Pharmacother; 2011 Apr; 12(5):685-90. PubMed ID: 21385109
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Adverse effects of local use of beta-blockaders in glaucoma. A literature review and a survey of reports to the adverse drug reaction authority 1986-95].
    Nygaard HA; Høvding G
    Tidsskr Nor Laegeforen; 1997 May; 117(14):2019-21. PubMed ID: 9235677
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuropsychiatric Adverse Events from Topical Ophthalmic Timolol.
    Cimolai N
    Clin Med Res; 2019 Dec; 17(3-4):90-96. PubMed ID: 31462538
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fixed combinations of dorzolamide-timolol and brimonidine-timolol in the management of glaucoma.
    Razeghinejad MR; Sawchyn AK; Katz LJ
    Expert Opin Pharmacother; 2010 Apr; 11(6):959-68. PubMed ID: 20307220
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Use of glaucoma medications during pregnancy and breastfeeding].
    Méndez-Hernández C
    Arch Soc Esp Oftalmol; 2012 Dec; 87(12):389-91. PubMed ID: 23121698
    [No Abstract]   [Full Text] [Related]  

  • 26. Peyronie's disease following long-term use of topical timolol.
    Ross JJ; Rahman I; Walters RF
    Eye (Lond); 2006 Aug; 20(8):974-6. PubMed ID: 16151480
    [No Abstract]   [Full Text] [Related]  

  • 27. [Acute systemic side-effects of topical timolol for glaucoma].
    Geyer O; Loewenstein A; Gertler-Hertz I; Lazar M
    Harefuah; 1992 Dec; 123(11):460-1, 506. PubMed ID: 1487203
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Raynaud syndrome following timolol-containing eyedrops].
    Meuche C; Heidrich H; Bleckmann H
    Fortschr Ophthalmol; 1990; 87(1):45-7. PubMed ID: 2323696
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alopecia Induced by Timolol Eye-drops.
    Muramatsu K; Nomura T; Shiiya C; Nishiura K; Tsukinaga I
    Acta Derm Venereol; 2017 Feb; 97(2):295-296. PubMed ID: 27545615
    [No Abstract]   [Full Text] [Related]  

  • 30. Serious Adverse Reaction to Timolol Eye Drops in a 7-Year-Old Boy With Glaucoma and Asthma.
    Cano-Mollinedo M; Rodríguez Del Río P; Sánchez-García S; Escudero C; Ibañez MD
    J Investig Allergol Clin Immunol; 2016; 26(6):379-381. PubMed ID: 27996947
    [No Abstract]   [Full Text] [Related]  

  • 31. The potential systemic effect of topically applied beta-blockers in glaucoma therapy.
    Taniguchi T; Kitazawa Y
    Curr Opin Ophthalmol; 1997 Apr; 8(2):55-8. PubMed ID: 10168358
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Bradyarrhythmias secondary to the use of ophthalmic timolol. A report of 3 cases].
    Anguita M; Torres F; Giménez D; Segura J; Aumente D; Suárez de Lezo J; Vallés F
    Rev Esp Cardiol; 1992 Jan; 45(1):71-3. PubMed ID: 1549765
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of silicone punctal plugs as adjuncts to topical pharmacotherapy of glaucoma--a pilot study. Punctal Plugs in Glaucoma Study Group.
    Bartlett JD; Boan K; Corliss D; Gaddie IB
    J Am Optom Assoc; 1996 Nov; 67(11):664-8. PubMed ID: 8979659
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic and systemic side effects of ocular beta-adrenergic antagonists in anesthetized dogs.
    Svec AL; Strosberg AM
    Invest Ophthalmol Vis Sci; 1986 Mar; 27(3):401-5. PubMed ID: 2869005
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Severe hyperkalemia as a complication of timolol, a topically applied beta-adrenergic antagonist.
    Swenson ER
    Arch Intern Med; 1986 Jun; 146(6):1220-1. PubMed ID: 3718111
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The extended ocular hypotensive effect of positive liposomal cholesterol bound timolol maleate in glaucomatous rabbits.
    Shafaa MW; Sabra NM; Fouad RA
    Biopharm Drug Dispos; 2011 Dec; 32(9):507-17. PubMed ID: 22028305
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ocular beta-blockers and systemic effects.
    Fraunfelder FT
    Arch Intern Med; 1986 Jun; 146(6):1073-4. PubMed ID: 2872865
    [No Abstract]   [Full Text] [Related]  

  • 38. Efficacy and systemic side-effects of topical 0.5% timolol aqueous solution and 0.1% timolol hydrogel.
    Uusitalo H; Niño J; Tahvanainen K; Turjanmaa V; Ropo A; Tuominen J; Kähönen M
    Acta Ophthalmol Scand; 2005 Dec; 83(6):723-8. PubMed ID: 16396651
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lichenoid drug eruption secondary to topical timolol and dorzolamide eye-drops.
    Mullins RJ; Lones R; Dutta B
    Australas J Dermatol; 2004 May; 45(2):151-2. PubMed ID: 15068470
    [No Abstract]   [Full Text] [Related]  

  • 40. [Indications and contraindications of beta blockaders in the treatment of glaucoma].
    Bleckmann H; Dorow P
    Dtsch Med Wochenschr; 1984 Feb; 109(5):180-3. PubMed ID: 6141926
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.